Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial

By Eastell R.   Lang T.   Boonen S.   Cummings S.   Delmas P.   Cauley J.   Horowitz Z.   Kerzberg E.   Bianchi G.   Kendler D.   Leung P.   Man Z.   Mesenbrink P.   Eriksen E.   Black D.  

Osteoporosis International, Vol. 21, Iss. 7, 2010-07 ,pp. : 1277-1285

Springer Publishing Company

Access to resources Recommend Favorite

Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy

By Kumm Jaanika   Ivaska Kaisa   Rohtla Kadri   Vaananen Kalervo   Tamm Agu  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 6, 2008-10 ,pp. : 459-463

Informa Healthcare

Access to resources Recommend Favorite

Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials

By  

Oncology Research and Treatment, Vol. 39, Iss. 7-8, 2016-06 ,pp. : 453-459

Karger

Access to resources Recommend Favorite

Well-Differentiated Hand Liposarcoma with Bone Metastases Treated Successfully with Zoledronic Acid

By  

Oncology Research and Treatment, Vol. 34, Iss. 12, 2011-11 ,pp. : 706-709

Karger

Access to resources Recommend Favorite

Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg

By Wark J.  

Osteoporosis International, Vol. 23, Iss. 2, 2012-02 ,pp. : 503-512

Springer Publishing Company

Access to resources Recommend Favorite